Enhanced duck hepatitis B virus gene expression following aflatoxin B1 exposure

Hepatology

Volumn 29, Issue 4, 1999, Pages 1317-1323

  Barraud, Luc ^a   Guerret, Sylviane ^b   Chevallier, Michele ^b   Borel, Christelle ^a   Jamard, Catherine ^a   Trepo, Christian ^a   Wild, Christopher P ^c   Cova, Lucyna ^a  

^a INSERM   (France)

^b LMM Laboratoire Marcel Merieux   (France)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; DIMETHYL SULFOXIDE; VIRUS DNA; VIRUS ENVELOPE PROTEIN; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DUCK; GENE EXPRESSION; HEPATITIS B; HEPATITIS B VIRUS; LIVER DISEASE; MALE; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; VIRUS REPLICATION;

EID: 0032955839     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290441     Document Type: Article

References (16)

1. Beasley RP. Hepatitis B virus as the etiologic agent in hepatocellular carcinoma: epidemiologic consideration. HEPATOLOGY 1986;2:21-26.
2. Ross KR, Yuan JM, Yu MC, Wogan GN, Qian GS, Tu JT, Groopman JD, et al. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 1992;339:943-946.
3. Qian SQ, Ross RK, Yu MC, Yuan JM, Gao YT, Henderson BE, Wogan GN, et al. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shangai, People's Republic of China. Cancer Epidemiol Biomarkers Prev 1994;3:3-10.
4. Chen CJ, Wang LY, Lu SN, Wu MH, You SL, Zhang YJ, Wang LW, et al. Elevated aflatoxin exposure and increased risk of hepatocellular carcinoma. HEPATOLOGY 1996;24:38-42.
5. Sell S, Hunt JM, Dunsford HA, Chisari FV. Synergy between hepatitis B virus expression and chemical hepatocarcinogens in transgenic mice. Cancer Res 1991;51:1278-1285.
6. Ghebranious N, Sell S. Hepatitis B injury, male gender, aflatoxin, and p53 expression each contribute to hepatocarcinogenesis in transgenic mice. HEPATOLOGY 1998;27:383-391.
7. 1 in woodchucks. Cancer Res 1995;55:3318-3330.
8. Marion PL, Knight SS, Ho BK, Robinson WS, Popper H. Liver disease associated with duck hepatitis B virus infection of domestic ducks. Proc Natl Acad Sci U S A 1984;81:898-902.
9. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991;350:427-428.
10. 1 and liver cancer in domestic Chinese ducks. Br J Cancer 1994;69:104-109.
11. Duflot A, Hollstein M, Mehrotra R, Trépo C, Montesano R, Cova L. Absence of p53 mutation at codon 249 in duck hepatocellular carcinomas from the high incidence area of Qidong (China). Carcinogenesis 1994;15:1353-1357.
12. Duflot A, Mehrotra R, Yu SZ, Barraud L, Trépo C, Cova L. Spectrum of liver disease and duck hepatitis B virus infection in a large series of Chinese ducks with hepatocellular carcinoma. HEPATOLOGY 1995;21:1483-1491.
13. 1 and hepatitis B virus infection in the induction of liver tumors in ducks. Cancer Res 1990;50:2156-2163.
14. 1-treated, congenital duck hepatitis B virus-infected, and virus-free Pekin ducks. Cancer Res 1990;50:4072-4080.
15. 1-DNA adduct in healthy males. Carcinogenesis 1997;18:1189-1194.
16. Wild CP, Fortuin M, Donato F, Whittle HC, Hall AJ, Wolf R, Montesano R. Aflatoxin, livers enzymes, and hepatitis B virus infection in Gambian children. Cancer Epidemiol Biomarkers Prev 1993;2:555-561.